Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis

BACKGROUND: Antiangiogenic therapy is one of the most significant advances in anticancer treatment. The benefits of antiangiogenic therapies of late-stage cancers have been investigated but are still too limited. METHODS: We used an ovarian cancer model to test the effect of short-term bevacizumab t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yuan, Li, Qin, Li, Xiao-Yu, Yang, Qiu-Ya, Xu, Wei-Wei, Liu, Gao-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310846/
https://www.ncbi.nlm.nih.gov/pubmed/22357313
http://dx.doi.org/10.1186/1756-9966-31-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310846/
https://www.ncbi.nlm.nih.gov/pubmed/22357313
http://dx.doi.org/10.1186/1756-9966-31-16

Ejemplares similares